Mesothelioma Immunotherapy Trial Involves Targeted Radiation – Asbestos.com
Asbestos.com |
Mesothelioma Immunotherapy Trial Involves Targeted Radiation
Asbestos.com Memorial Sloan Kettering Cancer Center in New York City has opened a clinical trial for mesothelioma involving a combination of targeted radiation and the novel immunotherapy drug avelumab. Hopes are high for the first-of-its kind study. The trial will … |
